CTRI/2020/08/027225已完成未知
Ivermectin as a potential treatment for COVID 19: A double blind randomized placebo-controlled trial
AIIMS Patna0 个研究点目标入组 115 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 115
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients admitted with COVID-19 with mild to moderate severity
排除标准
- •History of allergy to Ivermectin
- •Unwillingness to participate in the study
研究者
相似试验
进行中（未招募）
1 期
Pragmatic study CORIVER: Ivermectin as antiviral treatment for patients infected by SARS-COV2 (COVID19)EUCTR2020-001971-33-ESCarmen Hidalgo45
Unknown
2 期
The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial)Covid19NCT04712279Corpometria Institute294
已完成
4 期
Ivermectin Role in Covid-19 Clinical TrialCovid19NCT04746365Elaraby Hospital300
已完成
2 期
Ivermectin as a Novel Therapy in COVID-19 TreatmentCOVIDNCT04403555Tanta University164
Unknown
2 期
Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19Covid19NCT04716569South Valley University150